Current computational tools for de novo ligand design
- 1 August 1996
- journal article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 7 (4) , 433-436
- https://doi.org/10.1016/s0958-1669(96)80120-0
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Structure-Based Design of Novel HIV Protease Inhibitors: Carboxamide-Containing 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Potent Nonpeptidic InhibitorsJournal of Medicinal Chemistry, 1995
- Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2Nature Structural & Molecular Biology, 1995
- Design, Synthesis and Biological Actmty of Novel Rigid Amidino-Phenylalanine Derivatives as Inhibitors of ThrombinJournal of Enzyme Inhibition, 1995
- Structure-based drug design: progress, results and challengesStructure, 1994
- Novel Series of Achiral, Low Molecular Weight, and Potent HIV-1 Protease InhibitorsJournal of the American Chemical Society, 1994
- Application of the Three-Dimensional Structures of Protein Target Molecules in Structure-Based Drug DesignJournal of Medicinal Chemistry, 1994
- Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease InhibitorsScience, 1994
- Rational design of potent sialidase-based inhibitors of influenza virus replicationNature, 1993
- Use of structural information in drug design: Current Opinion in Structural Biology 1992, 2:202–210Current Opinion in Structural Biology, 1992
- Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucomaJournal of Medicinal Chemistry, 1989